In many cancer cells, the disruption of TGF-β signalling causes the simultaneous proliferation of both cancer cells and the surrounding stromal cells in an immunosuppressive and pro-angiogenic microenvironment [48]. The gene discussed is TGFB1; the disease is cancer.